Tian'an Pharmaceutical Co., Ltd. (TNPH) Research

Founded in Xi'an, China, in 2003, Tian'an Pharmaceutical Co., Ltd. focuses on the development, manufacturing, and sale of traditional Chinese herbal medicines. These remedies, offered in formats such as pills, hard capsules, and soft ointments, are intended for the prevention and treatment of various ailments within China. The company also dedicates efforts to the research and innovation of biological products and health supplements. Among its key pharmaceutical and nutraceutical offerings are the Compound Ginseng capsule, a traditional Chinese medicine designed to address prostate gland proliferation; Nizhuanle Yin granule, another Chinese medicine used for treating inflammation or deterioration of the stomach's mucous membrane; and the Tianan soft capsule, formulated to regulate elevated blood lipid levels, enhance blood flow, and improve vascular elasticity. Additionally, the Tianan Pain Relief Capsule, a Chinese medicine, is presently under development to alleviate a broad spectrum of pain, including joint discomfort, headaches, muscle injuries, cancer-related pain, gynecological disorders, and general aches. Tian'an Pharmaceutical distributes its products via independent distributors, who then supply them to pharmacies, drugstores, and hospitals.

Market snapshot

Symbol
TNPH
Price
$0.01
Day change
0.00%
Market cap
$147.0K
P/E ratio
1258.62x
52-week range
0.0024-0.045
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acura Pharmaceuticals, Inc. (ACUR)
  • Amazonas Florestal, Ltd (AZFL)
  • Curative Biosciences, Inc. (CBDX)
  • Cannonau Corp. (CNNC)
  • Filament Health Corp. (FLHLF)
  • G Medical Innovations Holdings Ltd (GMVDF)
  • Kali, Inc. (KALY)
  • Nutranomics, Inc. (NNRX)

Open Tian'an Pharmaceutical Co., Ltd. (TNPH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.